Quality Improvement for Institutions
www.cvquality.acc.org

Menu

Promoting Interoperability

Beginning in 2019, CMS states that participants will submit a single set of Promoting Interoperability Objectives and Measures that align with the 2015 Edition CEHRT. Measures will be organized according to 4 objectives categories (Public Health and Clinical Data Exchange, Electronic Prescribing, Provider to Patient Exchange, and Health Information Exchange) as oppose to previous classification as Base or Performance.

Please note, there are hardship exceptions that do apply to the use of a 2015 Edition CEHRT, click here to learn more. If you receive a hardship exception, the Promoting Interoperability performance category receives 0 weight in calculating your final score and the 25% is reallocated to the Quality performance category.

Scoring Promoting Interoperability in 2019 has been updated to reflect CMS changes for the Public Health and Clinical Data Exchange measures. Practices will be awarded full points if they participate and submit yes for two separate registries or one yes and one exclusion. Both the PINNACLE Registry and Diabetes Collaborative Registry qualify for the Public Health and Clinical Data Exchange measures as two registries.

You can learn more about these Promoting Interoperability scoring changes by clicking here.

Medicaid EHR Incentive Program

The Medicaid EHR is administered voluntarily by state and territories and is separate from QPP requirements. Eligible hospitals and eligible professionals (EP) that participate in the Medicaid EHR Incentive Program attest directly to the state. To view a list of the available Medicaid EHR states and websites, click here. Participants can choose to report under Modified Stage 2 objectives and measures or Stage 3 objectives and measures regardless of location.

The PINNACLE and Diabetes Collaborative Registries are both considered specialized registries for the Modified Stage 2 Specialized Registry Reporting and Stage 3 Clinical Data Registry Reporting measure.

Modified Stage 2 requires EPs to attest to at least three measures from the Public Health Reporting measures. Measure options include:

  1. Immunization Registry Reporting: The eligible hospital or CAH is in active engagement with a public health agency to submit immunization data.
  2. Syndromic Surveillance Reporting: The eligible hospital or CAH is in active engagement with a public health agency to submit syndromic surveillance data.
  3. Specialized Registry Reporting: The eligible hospital or CAH is in active engagement to submit data to a specialized registry.
  4. Electronic Reportable Laboratory Result Reporting: The eligible hospital or CAH is in active engagement with a public health agency to submit electronic reportable laboratory (ELR) results.

There are three ways to achieve active engagement for Modified Stage 2 Objectives:

  • Option 1: The MU program participant has registered with a Public Health Agency (PHA) or Clinical Data Registry (CDR) within 60 days after the start of the EHR reporting period and is awaiting an invitation from the PHA or CDR to begin testing and validation.
  • Option 2: The MU program participant is in the process of testing and validation of the electronic submission of data.
  • Option 3: The MU program participant has completed testing and is electronically submitting production data.

To access full Public Health Reporting Modified Stage 2 Objectives and Measures click here.

Stage 3 requires EPs to actively engage with a Public Health Agency (PHA) or clinical data registry (CDR) to submit electronic public health data in a meaningful way using Certified Electronic Health Record Technology (CEHRT), except where prohibited and in accordance with applicable law and practice. Measure options include:

  • Immunization Registry Reporting: The EP is in active engagement with a public health agency to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS).
  • Syndromic Surveillance Reporting: The EP is in active engagement with a public health agency to submit syndromic surveillance data from an urgent care setting.
  • Electronic Case Reporting: The EP is in active engagement with a public health agency to submit case reporting of reportable conditions.
  • Public Health Registry Reporting: The EP is in active engagement with a public health agency to submit data to public health registries.
  • Clinical Data Registry Reporting: The EP is in active engagement to submit data to a clinical data registry.

There are three ways to achieve active engagement for Stage 3 Objectives:

  • Option 1: The MU program participant has registered with a Public Health Agency (PHA) or Clinical Data Registry (CDR) within 60 days after the start of the EHR reporting period and is awaiting an invitation from the PHA or CDR to begin testing and validation.
  • Option 2: The MU program participant is in the process of testing and validation of the electronic submission of data.
  • Option 3: The MU program participant has completed testing and is electronically submitting production data.

To access full Public Health and Clinical Data Registry Reporting Stage 3 Objectives and Measures click here.


Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006